IE33016L - Antacid composition - Google Patents

Antacid composition

Info

Publication number
IE33016L
IE33016L IE690374A IE37469A IE33016L IE 33016 L IE33016 L IE 33016L IE 690374 A IE690374 A IE 690374A IE 37469 A IE37469 A IE 37469A IE 33016 L IE33016 L IE 33016L
Authority
IE
Ireland
Prior art keywords
phosphate
gluconate
calcium
antacid composition
april
Prior art date
Application number
IE690374A
Other versions
IE33016B1 (en
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of IE33016L publication Critical patent/IE33016L/en
Publication of IE33016B1 publication Critical patent/IE33016B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,200,157. Pharmaceutical vehicle; antacid composition. SMITH KLINE & FRENCH LABORATORIES. 1 April, 1969 [5 April, 1968], No. 17074/69. Heading A5B. An aqueous pharmaceutical vehicle comprises a combination of monobasic calcium phosphate and at least one of sodium, potassium, calcium or magnesium gluconate dissolved in water, wherein the phosphate and gluconate are each present in an amount from 0.5-7.0% W/V, provided that the total concentration of phosphate and gluconate is from 3-10% W/V. A liquid antacid composition comprises weight/volume of from 25-50% of solid antacid material suspended in an aqueous vehicle containing monobasic calcium phosphate and at least one of sodium, potassium calcium or magnesium gluconate. Conventional additives such as preservatives, flavours and solubilizers and anti-spasmodic agents or tranquilizers or glycine may also be present. [GB1200157A]
IE374/69A 1968-04-05 1969-03-21 Concentrated liquid antacid compositions IE33016B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71923468A 1968-04-05 1968-04-05

Publications (2)

Publication Number Publication Date
IE33016L true IE33016L (en) 1969-10-05
IE33016B1 IE33016B1 (en) 1974-02-20

Family

ID=24889291

Family Applications (1)

Application Number Title Priority Date Filing Date
IE374/69A IE33016B1 (en) 1968-04-05 1969-03-21 Concentrated liquid antacid compositions

Country Status (10)

Country Link
US (1) US3621094A (en)
AU (1) AU443154B2 (en)
BE (1) BE731060A (en)
DE (1) DE1915798C3 (en)
FR (1) FR2005599A1 (en)
GB (1) GB1200157A (en)
IE (1) IE33016B1 (en)
IL (1) IL31858A (en)
LU (1) LU58367A1 (en)
NL (1) NL6905135A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1076479A (en) * 1976-09-17 1980-04-29 Lewis/Howe Company Concentrated magnesium hydroxide suspensions or emulsions and method for production thereof
JPS58192739U (en) * 1982-06-19 1983-12-21 仁川　春夫 Vehicle towing repair car
DE8334745U1 (en) * 1983-12-03 1985-07-18 Schöberl, Franz, 8400 Regensburg Towing device for automobiles
US4548817A (en) * 1984-01-20 1985-10-22 Webb-Waring Lung Institute Composition and method for treating mammalian acidosis
JPS62502261A (en) * 1985-03-27 1987-09-03 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ↓−ポレイテッド Replenishment calcium addition unit
JPS62502967A (en) * 1985-04-18 1987-11-26 ザ・プロクター・アンド・ギャンブル・カンパニー Treatment of non-ulcer dyspepsia
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
AU679796B2 (en) * 1993-10-13 1997-07-10 Warner-Lambert Company Antacid pharmaceutical composition
US5455050A (en) * 1993-11-12 1995-10-03 Mcneil-Ppc, Inc. Aqueous antacids with calcium carbonate and magnesium salt
US5498426A (en) * 1994-10-03 1996-03-12 The Procter & Gamble Company Liquid antacid compositions
US20060257358A1 (en) * 2005-05-13 2006-11-16 Depuy Products, Inc. Suspension of calcium phosphate particulates for local delivery of therapeutic agents
WO2009037583A2 (en) * 2007-08-03 2009-03-26 Nucitec S.A. De C.V. Compositions and methods for treatment and prevention of osteoarthritis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062714A (en) * 1960-03-11 1962-11-06 Lewis Howe Company Antacid composition
US3215601A (en) * 1963-02-07 1965-11-02 Warner Lambert Pharmaceutical Antacid composition and method of making same
US3361769A (en) * 1964-01-22 1968-01-02 Synergistics Inc Bi-metallic salts of gluconic, glucuronic, or galacturonic acid
US3350266A (en) * 1964-06-04 1967-10-31 Bristol Myers Co Antacid composition comprising aluminum hydroxide, magnesium hydroxide and magnesium gluconate

Also Published As

Publication number Publication date
DE1915798A1 (en) 1969-11-06
IE33016B1 (en) 1974-02-20
DE1915798C3 (en) 1978-04-27
GB1200157A (en) 1970-07-29
FR2005599A1 (en) 1969-12-12
AU5219669A (en) 1970-09-24
LU58367A1 (en) 1970-11-09
AU443154B2 (en) 1973-11-28
US3621094A (en) 1971-11-16
DE1915798B2 (en) 1977-08-25
IL31858A (en) 1972-05-30
NL6905135A (en) 1969-10-07
FR2005599B1 (en) 1973-12-21
BE731060A (en) 1969-10-06
IL31858A0 (en) 1969-05-28

Similar Documents

Publication Publication Date Title
IE33016L (en) Antacid composition
GB1372008A (en) Water-in-oil emulsions
GB1430634A (en) Fibres of regenerated cellulose and polyacrylic acid salt of alkali-metals
DE3067351D1 (en) Dentifrice with high foaming ability
ES8600051A1 (en) Pharmaceutical composition
GB1313645A (en) Flavouring process employing and compositions containing 3-phenyl pentenals
AU462610B2 (en) Improvements in or relating to self-propelled vehicles
FR2548676B1 (en) BIOPOLYMER COMPOSITIONS AND THEIR PREPARATION PROCESS
IL37280A (en) Adenosine-5'-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
KR920008058A (en) Solid lactulose
GB1403900A (en) Pharmaceutical composition
BE769353A (en) BARBITURIC ACID DERIVATIVES AND CONTAINING COMPOSITIONS
CA981594A (en) Appareil pour la concentration d'un liquide contenant des elements non ultrafiltrables
GB1218460A (en) Lupus erythematosus skin test composition and its preparation
IE34609B1 (en) Antineoplastic therapeutic compositions
GB1310374A (en) Toothpaste composition
GB1449146A (en) Prostaglandins and the preparation thereof
SU378252A1 (en) METHOD OF REVERSE FLOTATION OF IRON ORES
CA985702A (en) Polymers of 1-butene-2,3,4-tricarboxylic acid and their use as detergent builders
BE784373A (en) PROCESS AND COMPOSITIONS FOR THE PREPARATION OF NON-ALCOHOLIC BEVERAGES AND CONCENTRATES FOR SUCH BEVERAGES
FR2469712A1 (en) ABRINE-CONTAINING IMMUNOPOTENTIALIZER AND THERAPEUTIC COMPOSITION CONTAINING THE SAME
Faisst The Aluminum Trailer
GB1201423A (en) Improvements in or relating to iron salt-antibiotic compositions
GB1283810A (en) Magnesium aspartate hydrohalides
Garfield Ultrastructural aspects of sodium transport in rat myometrium